Follow
Kapil Juvale
Kapil Juvale
NMIMS School of Pharmacy and Technology Management
Verified email at nmims.edu
Title
Cited by
Cited by
Year
Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein
K Juvale, VFS Pape, M Wiese
Bioorganic & medicinal chemistry 20 (1), 346-355, 2012
1412012
Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2
K Juvale, K Stefan, M Wiese
European journal of medicinal chemistry 67, 115-126, 2013
1072013
Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2)
K Juvale, J Gallus, M Wiese
Bioorganic & medicinal chemistry 21 (24), 7858-7873, 2013
1052013
4-Substituted-2-phenylquinazolines as inhibitors of BCRP
K Juvale, M Wiese
Bioorganic & medicinal chemistry letters 22 (21), 6766-6769, 2012
682012
Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights
S Puri, K Juvale
European journal of medicinal chemistry 199, 112393, 2020
672020
The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2)
S Kraege, K Stefan, K Juvale, T Ross, T Willmes, M Wiese
European Journal of Medicinal Chemistry 117, 212-229, 2016
602016
Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2
K Silbermann, CP Shah, NU Sahu, K Juvale, SM Stefan, PS Kharkar, ...
European Journal of Medicinal Chemistry 164, 193-213, 2019
432019
Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity
J Gallus, K Juvale, M Wiese
Biochimica et Biophysica Acta (BBA) - Biomembranes 1838 (11), 2929–2938, 2014
392014
Evaluation of dual P-gp-BCRP inhibitors as nanoparticle formulation
MS Singh, K Juvale, M Wiese, A Lamprecht
European Journal of Pharmaceutical Sciences 77, 1-8, 2015
242015
Cancer cell fusion: A potential target to tackle drug-resistant and metastatic cancer cells
C Fernandes, P Prabhu, K Juvale, D Suares, YC Mayur
Drug Discovery Today 24 (9), 1836-1844, 2019
232019
Evaluation of oxindole derivatives as a potential anticancer agent against breast carcinoma cells: In vitro, in silico, and molecular docking study
S Puri, I Ahmad, H Patel, K Kumar, K Juvale
Toxicology in Vitro 86, 105517, 2023
212023
Inhibitors of inosine 5′-monophosphate dehydrogenase as emerging new generation antimicrobial agents
K Juvale, A Shaik, S Kirubakaran
Medchemcomm 10 (8), 1290-1301, 2019
202019
Design of inhibitors of BCRP/ABCG2
K Juvale, M Wiese
Future Medicinal Chemistry 7 (12), 1521-1527, 2015
142015
Synthesis and evaluation of phenytoin derivatives as anticonvulsant agents
M Deodhar, P Sable, A Bhosale, K Juvale, R Dumbare, P Sakpal
Turkish Journal of Chemistry 33 (3), 367-373, 2009
142009
Indole derivatives as new structural class of potent and antiproliferative inhibitors of monocarboxylate transporter 1 (MCT1; SLC16A1)
S Puri, K Stefan, SL Khan, J Pahnke, SM Stefan, K Juvale
Journal of Medicinal Chemistry 66 (1), 657-676, 2022
132022
Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection
K Juvale, G Purushothaman, V Singh, A Shaik, S Ravi, V Thiruvenkatam, ...
Scientific Reports 9 (1), 190, 2019
102019
Formulation and optimization of gefitinib-loaded nanosuspension prepared using a newly developed dendritic lipopeptide oligomer material
N Hegde, K Juvale, B Prabhakar
Chemical Papers, 1-16, 2021
72021
Synthesis and in vitro enzymatic studies of new 3-aryldiazenyl indoles as promising Helicobacter pylori IMPDH inhibitors
S Jangra, G Purushothaman, K Juvale, S Ravi, A Menon, ...
Current Topics in Medicinal Chemistry 19 (5), 376-382, 2019
72019
Long circulating polymeric nanoparticles of gemcitabine HCl using PLGA-PEG-PPG-PEG block co-polymer
K Kale, A Fulfager, K Juvale, KS Yadav
International Journal of Polymeric Materials and Polymeric Biomaterials 73 …, 2024
52024
Facile synthesis of new N1-alkylated 1H-indazole-3-carboxamide derivatives as potential anticancer agents: In vitro, ADMET prediction, and SAR studies
S Puri, K Juvale
Journal of Molecular Structure 1269, 133727, 2022
52022
The system can't perform the operation now. Try again later.
Articles 1–20